fda banning compounded tirzepatide Seattle weight loss patients fret over limits on off-brand drugs FDA moves to remove GLP-1

And remember that any supplement shouldnt be viewed as a cure or a replacement for medications

More patients receiving semaglutide 1 mg achieved weight loss of 5 % and 10 % (up to 63 % and 27 %) versus patients receiving dulaglutide 1.5 mg (30 % and 8 %)

Researchers from Cleveland Clinic analyzed electronic health record data to identify adults with overweight or obesity who used semaglutide (Ozempic/Wegovy, Novo Nordisk) or tirzepatide (Mounjaro/Zepbound, Eli Lilly) from 2021 to 2024

Already know the benefits of each ingredient

Vinicius Strano, executive director and head of research at UBS BB, noted that formal GLP-1 sales in Brazil currently reach less than 1% of the countrys adult population, signaling substantial room for expansion